Showing results (1-10 of 249) with videos related to
Sort By:
Pageof 25
Anaesthesia|December 3, 2014
Management of peri-operative anti-thrombotic therapyJ J van Veen, M MakrisBritish Journal of Haematology|June 20, 2008
Thrombin generation testing in routine clinical practice: are we there yet?J J van Veen, A Gatt, M MakrisHaemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2014
Major surgery in severe haemophilia A with inhibitors using a recombinant factor VIIa and activated prothrombin complex concentrate hybrid regimenJ J van Veen, R M Maclean, K K Hampton, et al.Journal of Thrombosis and Haemostasis : JTH|July 7, 2009
Optimizing warfarin reversal--an ex vivo studyA Gatt, A Riddell, J J van Veen, et al.International Journal of Laboratory Hematology|January 15, 2008
The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agentsJ J van Veen, A Gatt, A E Bowyer, et al.British Journal of Haematology|June 25, 2008
Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammationA Gatt, J J van Veen, A Bowyer, et al.Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort studyD Posthouwer, T T Yee, M Makris, et al.International Journal of Laboratory Hematology|October 1, 2010
The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normalA Bowyer, J Smith, A M Woolley, et al.International Journal of Laboratory Hematology|May 1, 2018
Argatroban is stable in citrated whole blood for 24 hoursS Guy, S Kitchen, J J Van VeenInternational Journal of Laboratory Hematology|August 26, 2015
Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatrobanS Guy, S Kitchen, R Maclean, et al.Pageof 25